LONDON, June 4 (Reuters) - A new version of AstraZeneca Plc's Symbicort asthma drug, which can be used simultaneously as maintenance and reliever therapy, has been launched in Britain, the company ...

March 19, 2007 — Health Canada has approved budesonide plus formoterol fumarate dehydrate inhalation aerosol with a flexible regimen for the maintenance and rescue treatment of asthma in patients aged ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD). It contains an inhaled corticosteroid called budesonide ...

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...

Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®. Breyna is a metered-dose inhaler ...

Wilmington, DE – June 4, 2008 – AstraZeneca (NYSE: AZN) today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...

If you have a certain kind of breathing condition, your doctor might suggest Symbicort as a treatment option. It’s a prescription drug used to treat the following: chronic obstructive pulmonary ...

AstraZeneca announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent for Symbicort (formoterol and budesonide) (EPB0613371 ...

Viatris Inc. VTRS announced that the company and partner Kindeva Drug Delivery L.P. have won a court decision that invalidates AstraZeneca's AZN patent for Symbicort. The U.S. District Court for the ...

The price you pay for Symbicort may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. You may be able to lower your long-term costs by getting a ...